A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. Read more trending ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

Nearly 80% of patients who suffered from a variety of cancer types were successfully treated with only immunotherapy, according to a new study published in The New England Journal of Medicine.

as the immunotherapy drug can more easily target the many mutations, per the study. “We’re really excited to help more people,” Dr. Cercek said. “And we are already exploring why rectal ...

He's part of an immunotherapy study that could fundamentally change the way certain cancers are treated. Cancers with certain mutations can put the brakes on our immune system, allowing what's ...

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

Spill, who has no family history of colorectal cancer, was among more than 100 adults in the United States who completed cancer treatment in a new study using only the immunotherapy drug ...